Senseonics Holdings (SENS) Cash from Investing Activities (2015 - 2026)
Senseonics Holdings' (SENS) quarterly Cash from Investing Activities came in at $18.0 million in Q1 2026, up 171.06% year-on-year from $6.6 million in Q1 2025, and down 20.52% on a QoQ basis from $22.6 million in Q4 2025.
Senseonics Holdings (SENS) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Cash from Investing Activities data on file, last reported at $18.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 171.06% year-over-year to $18.0 million in Q1 2026; TTM through Mar 2026 was -$10.1 million, a 43.46% increase from a year earlier, with the FY2025 full-year figure at -$53.4 million, down 262.68% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $18.0 million, down from $22.6 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for SENS reached as high as $47.7 million in Q4 2024 and fell as low as -$69.6 million in Q2 2025.
- Historically, Cash from Investing Activities has averaged $6.7 million across 5 years, with a median of $18.9 million in 2025.
- Across the five-year window, Cash from Investing Activities soared 178881.82% in 2022 and slumped 967.93% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at $7.4 million in 2022, then soared by 392.45% to $36.2 million in 2023, then jumped by 31.69% to $47.7 million in 2024, then sank by 52.5% to $22.6 million in 2025, then declined by 20.52% to $18.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $18.0 million in Q1 2026, $22.6 million in Q4 2025, and $18.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Senseonics Holdings | 229.57 Mn | 165.25 Mn | 6.94 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.00 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 22.64 Mn |
| Dec 31, 2025 | 22.64 Mn |
| Sep 30, 2025 | 18.89 Mn |
| Sep 30, 2025 | 18.89 Mn |
| Jun 30, 2025 | -69.63 Mn |
| Jun 30, 2025 | -69.63 Mn |
| Mar 31, 2025 | -25.33 Mn |
| Mar 31, 2025 | -25.33 Mn |
| Dec 31, 2024 | 47.67 Mn |
| Dec 31, 2024 | 47.67 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | -43.53 Mn |
| Jun 30, 2024 | -43.53 Mn |
| Mar 31, 2024 | 25.38 Mn |
| Mar 31, 2024 | 25.38 Mn |
| Dec 31, 2023 | 36.20 Mn |
| Dec 31, 2023 | 36.20 Mn |